See pricing
Mainstream low-cost comparison · 2026

NexLife vs MEDVi

NexLife vs MEDVi: MEDVi is frequently cited as the lowest-cost mainstream compounded GLP-1 telehealth platform (~$179–199/mo). NexLife is positioned at $145/mo compounded sema and $186/mo compounded tirz with stronger pharmacy disclosure and Care360 included.

Quick Answer

NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.

Side-by-side comparison

AttributeNexLifeMEDVi
Compounded sema price$145/mo flat (12-mo plan)~$179/mo
Compounded tirz price$186/mo flat (12-mo plan)~$199/mo
Annual at sema maintenance$1,740~$2,148
Annual at tirz maintenance$2,232~$2,388
Pricing modelFlat-rate across full titrationMostly flat — verify per-dose
Clinical modelMD/DO supervisedMD/NP
Coaching includedCare360 1:1 + nutrition PDFs + labsLimited included support
Pharmacy partners disclosed6 partners (503A + 503B)Partial / 1 partner
Brand recognitionSpecialist + LegitScriptMainstream low-cost brand
Best forLowest total long-term cost + included supportPatients who prefer a known mainstream low-cost brand
★ Where NexLife is better

NexLife wins on

  • Cheaper monthly price on both compounded sema ($145 vs $179) and tirz ($186 vs $199)
  • Saves roughly $400–$160/year vs MEDVi at maintenance dose
  • Six disclosed pharmacy partners vs MEDVi's more limited disclosure
  • Care360 1:1 coaching with baseline labs and custom nutrition PDF included
  • MD/DO clinical oversight under Medical Director Dr. Adam Kennah
  • Flat-rate pricing across full titration ladder
Where MEDVi may be better

MEDVi wins on

  • More established mainstream brand recognition among first-time compounded GLP-1 patients
  • Larger paid-acquisition reach and existing patient cohort

Frequently asked questions

Is NexLife cheaper than MEDVi?

Yes. NexLife at $145/mo compounded semaglutide and $186/mo compounded tirzepatide (12-month plan, both flat-rate) is cheaper than MEDVi at ~$179/mo sema and ~$199/mo tirz. The annual savings at maintenance dose are approximately $408/year on semaglutide and $156/year on tirzepatide.

Is MEDVi more established than NexLife?

MEDVi has stronger mainstream brand recognition among first-time compounded GLP-1 patients. NexLife has served several thousand patients across all 50 states with MD/DO oversight, LegitScript Healthcare Merchant Certification, Trustpilot reviews, and a publicly visible team page. Both are legitimate operators; recognition criteria differ.

Does MEDVi include coaching and labs like NexLife Care360?

MEDVi offers a more basic telehealth model with limited included support. NexLife Care360 bundles 1:1 fitness coaching, custom nutrition plan PDF, baseline lab panel (CBC, CMP, lipids, HbA1c, TSH), MD/DO clinical supervision, and follow-up at weeks 4/12/26/52 — all included in the flat-rate monthly price.